Loading…
IDEXX Laboratories, Inc. is projected to rise to $595.44 by 2027, a +8% move from its current price of $550.99. IDXX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $542.83 | $550.92 | $559.13 | -0.01% |
| May 30 | $539.45 | $550.85 | $562.49 | -0.03% |
| May 31 | $536.85 | $550.78 | $565.06 | -0.04% |
| Jun 1 | $534.66 | $550.71 | $567.23 | -0.05% |
| Jun 2 | $532.73 | $550.63 | $569.14 | -0.06% |
| Jun 3 | $530.98 | $550.56 | $570.87 | -0.08% |
| Jun 4 | $529.37 | $550.49 | $572.45 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $529.37 | $550.49 | $572.45 | -0.09% |
| Week 2 | $520.39 | $550.00 | $581.28 | -0.18% |
| Week 3 | $513.50 | $549.50 | $588.02 | -0.27% |
| Week 4 | $507.69 | $549.00 | $593.68 | -0.36% |
| Week 5 | $502.57 | $548.51 | $598.65 | -0.45% |
| Week 6 | $497.94 | $548.01 | $603.12 | -0.54% |
| Week 7 | $493.68 | $547.52 | $607.22 | -0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IDEXX Laboratories, Inc. is a healthcare company that develops, manufactures, and distributes products for the companion animal veterinary market, as well as livestock and poultry health, dairy testing, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
It offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides veterinary services, consulting, and cloud-based VetConnect PLUS technology for veterinarians. IDEXX Laboratories, Inc.
was incorporated in 1983 and is headquartered in Westbrook, Maine.
IDXX currently trades at $559.37, with a market cap of $44.12B and a rank of 334. The stock sits near technical support and shows a price outlook that improves over time according to the forecast, with long-run upside potential. Forecasts show a rising average price in the coming years, including 2026 at an avg of $557.97, 2027 at $587.22, 2028 at $690.25, 2029 at $767.09, and 2030 at $797.95, signaling a bullish trajectory beyond the near term.
Beyond 2030, the forecast projects continued strength, with 2040 avg $1,328.90 and 2050 avg $2,654.18, accompanied by substantial upside in the max values. The data also indicates rising bullish sentiment from 2028 onward, but notes a high level of volatility (annualized 40%).
A major floor 10.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.0% below — buyers have tended to step in here.
The nearest ceiling, 6.9% above — a clean break opens room to run.
A major ceiling 29.8% above — clearing it would confirm fresh momentum.
Key IDXX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IDXX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $554.84 | Sell | $552.73 | Sell |
| MA 10 | $545.68 | Buy | $551.14 | Sell |
| MA 20 | $552.11 | Sell | $553.84 | Sell |
| MA 50 | $565.26 | Sell | $570.84 | Sell |
| MA 100 | $610.83 | Sell | $594.95 | Sell |
| MA 200 | $639.12 | Sell | $600.70 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.79 | Neutral |
| Stoch RSI (14) | 73.95 | Neutral |
| CCI (20) | -6.39 | Neutral |
| Williams %R (14) | -48.74 | Info |
| MACD (12,26,9) | 2.34 | Buy |
| ROC (12) | -1.63 | Sell |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 51.26 | Neutral |
| TRIX (15) | -0.20 | Sell |
| Awesome (5,34) | -6.59 | Sell |
| Ultimate (7,14,28) | 61.37 | Neutral |
| Momentum (10) | 17.07 | Buy |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 560.11 | Sell |
| ADX (14) | 11.97 | Neutral |
| ATR (14) | 7.39 | Info |
The 30-day technical picture is neutral, with RSI(14) at 50 and a current stance around the middle of the range. SMA50 is $566.29 and SMA200 is $640.11, suggesting near-term equilibrium with a slight bias toward the longer-term moving average. The 30-day range spans from $503.79 to $617.97, with a nearest support level at $528.68 and a nearby resistance around $589.25.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $528.68 | $550.99 | $699.52 | 0% | Neutral | |
| $486.43 | $595.44 | $762.93 | +8% | Neutral | |
| $566.72 | $706.38 | $928.72 | +28% | Bullish | |
| $625.45 | $791.39 | $1,062.14 | +44% | Bullish | |
| $648.40 | $831.36 | $1,135.54 | +51% | Bullish | |
| $676.96 | $878.46 | $1,218.57 | +59% | Bullish | |
| $691.67 | $907.60 | $1,276.69 | +65% | Bullish | |
| $711.66 | $943.60 | $1,344.34 | +71% | Bullish | |
| $745.99 | $998.89 | $1,439.96 | +81% | Bullish | |
| $870.40 | $1,176.45 | $1,714.65 | +114% | Bullish | |
| $1,026.78 | $1,447.23 | $2,209.79 | +163% | Bullish | |
| $1,943.15 | $2,936.90 | $4,805.57 | +433% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $528.68 | $550.99 | $645.53 | +0.00% |
| June 2026 | $470.00 | $548.28 | $652.01 | -0.49% |
| July 2026 | $464.12 | $544.54 | $653.69 | -0.68% |
| August 2026 | $472.50 | $556.87 | $673.35 | +2.26% |
| September 2026 | $473.39 | $560.00 | $681.15 | +0.56% |
| October 2026 | $461.70 | $548.03 | $670.19 | -2.14% |
| November 2026 | $462.58 | $550.72 | $676.65 | +0.49% |
| December 2026 | $474.74 | $566.81 | $699.52 | +2.92% |
Click any year to see its month-by-month IDXX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, IDXX could reach as high as $699.52, with a base case around $550.99 and support toward $528.68 — roughly 0% from $550.99. Price action looks broadly range-bound.
Expect IDXX to range from $486.43 to $762.93 through 2027. The $595.44 average target implies a +8% move from current prices. That is up +8% on the projected 2026 average. A consolidation phase looks the most probable path here.
The IDXX price prediction for 2028 points to an average of $706.38 (low $566.72, high $928.72) — a potential gain of +28% on today's $550.99. Momentum favours further upside here.
In 2029, IDXX is projected to trade between $625.45 and $1,062.14, averaging $791.39 — a potential gain of +44% from today's $550.99. That is up +12% on the projected 2028 average. Buyers look set to stay in control over this stretch.
IDEXX Laboratories, Inc.'s 2030 outlook centres on $831.36, within a $648.40 to $1,135.54 range. That is up +5% on the projected 2029 average. That marks a +51% change versus current levels. Momentum favours further upside here.
By 2031, IDXX could reach as high as $1,218.57, with a base case around $878.46 and support toward $676.96 — roughly +59% from $550.99. Buyers look set to stay in control over this stretch.
Expect IDXX to range from $691.67 to $1,276.69 through 2032. The $907.60 average target implies a +65% move from current prices. That is up +3% on the projected 2031 average. Momentum favours further upside here.
The IDXX price prediction for 2033 points to an average of $943.60 (low $711.66, high $1,344.34) — a potential gain of +71% on today's $550.99. Buyers look set to stay in control over this stretch.
In 2034, IDXX is projected to trade between $745.99 and $1,439.96, averaging $998.89 — a potential gain of +81% from today's $550.99. That is up +6% on the projected 2033 average. Momentum favours further upside here.
IDEXX Laboratories, Inc.'s 2035 outlook centres on $1,176.45, within a $870.40 to $1,714.65 range. That is up +18% on the projected 2034 average. That marks a +114% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, IDXX could reach as high as $2,209.79, with a base case around $1,447.23 and support toward $1,026.78 — roughly +163% from $550.99. Momentum favours further upside here.
Expect IDXX to range from $1,943.15 to $4,805.57 through 2050. The $2,936.90 average target implies a +433% move from current prices. That is up +103% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in IDXX today (≈ 1.814915 IDXX) could be worth
$5,330.23
+$4,330.23 (+433%) by 2050 · US Dollar
Based on the average projected IDXX price of $2,936.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IDXXwould be worth at today's price.
$1,000 invested in IDXX on May 27, 2025 (≈ 1.936108 IDXX) would be worth
$1,066.78
+$66.78 (+6.7%) today · 1.07× · US Dollar
Based on a IDXX entry price of $516.5 vs. today's $550.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $553.58 | $995.32 | -0.5% |
| 1 month ago | $574.95 | $958.33 | -4.2% |
| 3 months ago | $660.71 | $833.94 | -16.6% |
| 6 months ago | $752.88 | $731.84 | -26.8% |
| 1 year ago | $516.5 | $1,066.78 | +6.7% |
| All time (5.0y) ago | $550.59 | $1,000.73 | +0.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IDXX forecast.
Our base-case forecast reaches $1,100.00 around 2035.
Implied market cap at $1,100.00: $86.77B
The multi-year outlook starts to build bullish momentum from 2028 onward, with 2028 and 2029 labeled as BULLISH and continuing through 2030 and beyond. By 2030 the forecast shows an avg price of $797.95 and a max of $1,090.17, with an estimated ROI of 43 and a bullish sentiment. By 2040 the avg rises to $1,328.90 and the max to $2,029.36, with ROI of 138.2 and a continued bullish stance.
By 2050 the avg is projected at $2,654.18 and the max at $4,343.35, with ROI of 375.7 and a sustained bullish outlook, reflecting strong long-term upside potential. The forecast highlights rising volatility (annualized 40%) and emphasizes that these figures are estimates, not guarantees, of future performance.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $797.95 and a max of $1,090.17, with an ROI of 43 and a bullish sentiment.
Forecasts show a path from 2026 with an avg of $557.97 to 2030 with an avg of $797.95 and rising to 2040 ($1,328.90) and 2050 ($2,654.18). The ROI figures become progressively larger (0 in 2026, 5.2 in 2027, 23.7 in 2028, 37.5 in 2029, 43 in 2030, 51.5 in 2031, up to 375.7 in 2050), and the sentiment turns bullish after 2027. However, volatility is noted at 40%, so these are estimates, not guarantees.
Yes. The forecast shows a 2029 max of $1,029.82 and a 2030 max of $1,090.17, indicating a path to around or above $1,000 in the near to mid term.
The 2050 forecast lists an avg of $2,654.18 and a max of $4,343.35, with an ROI of 375.7 and bullish sentiment.
IDEXX Laboratories, Inc. Community Discussion
0Share your IDEXX Laboratories, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.